Researchers Receive NIH Funds for Adjuvant Research to Boost Coronavirus Vaccines

Related Images

News Image Block

Researchers have received funding from the National Institute of Allergy and Infectious Diseases to screen and evaluate certain molecules known as adjuvants that may improve the ability of coronavirus vaccines to stimulate the immune system and generate appropriate responses necessary to protect the general population against the virus. (Credit: Getty Images, not for republication)

Krishnendu Roy, a professor and Robert A. Milton Chair in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. Roy’s research team has received NIH funding to screen and evaluate certain molecules known as adjuvants that may improve the ability of coronavirus vaccines to stimulate the immune system. (Credit: Rob Felt, Georgia Tech)